BMC oral health
Effectiveness of 0.1% triamcinolone acetonide compared with those of other therapies for minor recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials.
Anas Saeed Al-Zaghruri, Mohammed M Al Moaleem, Ahmed Yaseen Alqutaibi, Abbas Ahmed Abdulqader, Baleegh Abdulraoof Al-Kadasi, Nashwan Abduljabbar Noman, Ayman Ali Saad, Ammar Ahmed Al-Hiagem, Magdi Abdullah Abdulsalam
Published: 202510.1186/s12903-025-07358-4
Abstract
BACKGROUND: Recurrent aphthous stomatitis (RAS) is a common oral mucosal condition affecting over 2.5 billion people worldwide. Although 0.1% triamcinolone acetonide is a standard treatment, its comparative efficacy remains uncertain. OBJECTIVE: To e…
Preview only. Read the full abstract at the source